Human Herpesvirus 8 (HHV8) Sequentially Shapes the NK Cell Repertoire during the Course of Asymptomatic Infection and Kaposi Sarcoma
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Human Herpesvirus 8 (HHV8) Sequentially Shapes the NK Cell Repertoire during the Course of Asymptomatic Infection and Kaposi Sarcoma
Authors
Keywords
-
Journal
PLoS Pathogens
Volume 8, Issue 1, Pages e1002486
Publisher
Public Library of Science (PLoS)
Online
2012-01-13
DOI
10.1371/journal.ppat.1002486
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functional Consequences of Interactions between Human NKR-P1A and Its Ligand LLT1 Expressed on Activated Dendritic Cells and B Cells
- (2014) D. B. Rosen et al. JOURNAL OF IMMUNOLOGY
- Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells
- (2011) Jinjong Myoung et al. JOURNAL OF CLINICAL INVESTIGATION
- KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation
- (2011) Lynn M. Hassman et al. JOURNAL OF CLINICAL INVESTIGATION
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
- Modulation of NKp30- and NKp46-Mediated Natural Killer Cell Responses by Poxviral Hemagglutinin
- (2011) Mostafa Jarahian et al. PLoS Pathogens
- Piracy of Prostaglandin E2/EP Receptor–Mediated Signaling by Kaposi's Sarcoma-Associated Herpes Virus (HHV-8) for Latency Gene Expression: Strategy of a Successful Pathogen
- (2010) Arun George Paul et al. CANCER RESEARCH
- Modulation of natural killer cell activity by viruses
- (2010) Vanda Juranić Lisnić et al. CURRENT OPINION IN MICROBIOLOGY
- CD56 negative NK cells: origin, function, and role in chronic viral disease
- (2010) Niklas K. Björkström et al. TRENDS IN IMMUNOLOGY
- Kaposi's Sarcoma Associated Herpes Virus (KSHV) Induced COX-2: A Key Factor in Latency, Inflammation, Angiogenesis, Cell Survival and Invasion
- (2010) Neelam Sharma-Walia et al. PLoS Pathogens
- Hepatitis C Virus (HCV) Evades NKG2D-Dependent NK Cell Responses through NS5A-Mediated Imbalance of Inflammatory Cytokines
- (2010) Damien Sène et al. PLoS Pathogens
- NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo
- (2009) Tadepally Lakshmikanth et al. JOURNAL OF CLINICAL INVESTIGATION
- The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
- (2009) Cameron S. Brandt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Tumor-Shed PGE2 Impairs IL2Rγc-Signaling to Inhibit CD4+ T Cell Survival: Regulation by Theaflavins
- (2009) Sreya Chattopadhyay et al. PLoS One
- HLA-G homodimer-induced cytokine secretion through HLA-G receptors on human decidual macrophages and natural killer cells
- (2009) C. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity
- (2009) M. Balsamo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor-Associated MICA Is Shed by ADAM Proteases
- (2008) I. Waldhauer et al. CANCER RESEARCH
- NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy
- (2008) Nadia Guerra et al. IMMUNITY
- Ketosis-Prone Type 2 Diabetes Mellitus and Human Herpesvirus 8 Infection in Sub-Saharan Africans
- (2008) Eugène Sobngwi JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Up on the tightrope: natural killer cell activation and inhibition
- (2008) Lewis L Lanier NATURE IMMUNOLOGY
- NKG2D ligands in tumor immunity
- (2008) N Nausch et al. ONCOGENE
- Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity
- (2008) M. Thomas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started